[go: up one dir, main page]

PT97562A - Processo para a preparacao de uma composicao farmaceutica contendo um nucleo de diclofenac ou de piroxicamo e um revestimento de cobertura de uma prostaglandina - Google Patents

Processo para a preparacao de uma composicao farmaceutica contendo um nucleo de diclofenac ou de piroxicamo e um revestimento de cobertura de uma prostaglandina

Info

Publication number
PT97562A
PT97562A PT97562A PT9756291A PT97562A PT 97562 A PT97562 A PT 97562A PT 97562 A PT97562 A PT 97562A PT 9756291 A PT9756291 A PT 9756291A PT 97562 A PT97562 A PT 97562A
Authority
PT
Portugal
Prior art keywords
coating
diclofenac
pharmaceutical composition
pyroxicamo
prostaglandine
Prior art date
Application number
PT97562A
Other languages
English (en)
Other versions
PT97562B (pt
Inventor
Isabelle Maroteaux
Barbara J Struthers
Rene Antoine Gimet
Jean Charles Jinot
Christian Magnet
Francoise M Nevoux
Roger Scoyer
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24063571&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT97562(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Searle & Co filed Critical Searle & Co
Publication of PT97562A publication Critical patent/PT97562A/pt
Publication of PT97562B publication Critical patent/PT97562B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT97562A 1990-05-03 1991-05-03 Processo para a preparacao de uma composicao farmaceutica contendo um nucleo de diclofenac ou de piroxicamo e um revestimento de cobertura de uma prostaglandina PT97562B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51835390A 1990-05-03 1990-05-03

Publications (2)

Publication Number Publication Date
PT97562A true PT97562A (pt) 1992-02-28
PT97562B PT97562B (pt) 1998-08-31

Family

ID=24063571

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97562A PT97562B (pt) 1990-05-03 1991-05-03 Processo para a preparacao de uma composicao farmaceutica contendo um nucleo de diclofenac ou de piroxicamo e um revestimento de cobertura de uma prostaglandina

Country Status (15)

Country Link
US (2) US5601843A (pt)
EP (1) EP0527887B1 (pt)
AT (1) ATE121625T1 (pt)
AU (1) AU7876491A (pt)
CA (1) CA2082944C (pt)
DE (1) DE69109286T2 (pt)
DK (1) DK0527887T3 (pt)
ES (1) ES2071312T3 (pt)
GR (1) GR3015939T3 (pt)
IE (1) IE68596B1 (pt)
IL (1) IL98033A (pt)
NZ (1) NZ238024A (pt)
PT (1) PT97562B (pt)
WO (1) WO1991016895A1 (pt)
ZA (1) ZA913353B (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0527887T3 (da) * 1990-05-03 1995-07-03 Searle & Co Farmaceutisk præparat
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5324746A (en) * 1993-02-12 1994-06-28 Mckee Rex N Method of treating damaged mucosal and epithelial tissues with misoprostol
DE4341442C2 (de) * 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
CA2231550A1 (en) * 1995-09-27 1997-04-03 Merck Frosst Canada Inc. Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20010021625A (ko) 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
GB9814215D0 (en) * 1998-07-01 1998-09-02 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
GB9819685D0 (en) * 1998-09-10 1998-11-04 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6514525B2 (en) 1998-09-10 2003-02-04 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
US7429407B2 (en) * 1998-12-30 2008-09-30 Aeromatic Fielder Ag Process for coating small bodies, including tablets
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
CA2277407A1 (en) * 1999-07-14 2001-01-14 Bernard Charles Sherman Pharmaceutical tablet comprising an nsaid and misoprostol
JP2003510347A (ja) * 1999-10-01 2003-03-18 ノートン ヘルスケアー リミテッド 抗炎症医薬品製剤
US6761895B2 (en) * 2000-04-17 2004-07-13 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for averting pharmacokinetic drug interaction and method thereof
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP2316469A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
WO2004064815A1 (en) * 2003-01-21 2004-08-05 Smartrix Technologies Inc. Oral dosage formulation
DE602004007315D1 (de) * 2003-03-03 2007-08-16 Personnes A Responsibilite Lim Stabilisierte pharmazeutische Zusammensetzung enthaltend einen NSAID und einen Prostaglandin
WO2004091579A1 (en) * 2003-04-16 2004-10-28 Pharmacia Corporation Stabilized prostaglandin formulation
US7241746B2 (en) 2003-08-06 2007-07-10 Regena Therapeutics, Lc Method and composition for treating periodontal disease
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system
US8067451B2 (en) 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US20150224056A1 (en) * 2006-07-18 2015-08-13 Horizon Pharma Usa, Inc. Pharmaceutical compositions of ibuprofen and famotidine
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
EP2063873A2 (en) * 2006-08-31 2009-06-03 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
WO2008146178A2 (en) 2007-05-30 2008-12-04 Wockhardt Research Centre A novel tablet dosage form
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
EP2210595A1 (en) 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
JP2012531430A (ja) * 2009-06-25 2012-12-10 ポーゼン インコーポレイテッド アスピリン療法を必要とする患者を治療するための方法
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
EA028049B1 (ru) 2011-12-28 2017-10-31 Поузен Инк. Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
WO2017180259A1 (en) * 2016-04-11 2017-10-19 University Of Utah Research Foundation Methods for treating nsaid-induced cardiovascular, cerebrovascular, or renovascular adverse events

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135881B (en) * 1983-03-02 1986-09-17 Erba Farmitalia Pharmaceutical compositions for inhibiting or reducing gastrointestinal side effects of non-steroidal anti-inflammatory drugs
IT1190400B (it) * 1985-10-04 1988-02-16 Istituto Biochimico Italiano Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method
US4975283A (en) * 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
DE3603576A1 (de) * 1986-02-06 1987-08-13 Code Kaffee Handel Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz
JPH01139528A (ja) * 1987-11-24 1989-06-01 Showa Denko Kk 抗潰瘍剤
DK0527887T3 (da) * 1990-05-03 1995-07-03 Searle & Co Farmaceutisk præparat

Also Published As

Publication number Publication date
GR3015939T3 (en) 1995-07-31
IE68596B1 (en) 1996-06-26
IE911486A1 (en) 1991-11-06
US5601843A (en) 1997-02-11
NZ238024A (en) 1993-08-26
CA2082944C (en) 1998-11-24
ZA913353B (en) 1993-04-28
DE69109286D1 (de) 1995-06-01
IL98033A (en) 1995-07-31
DK0527887T3 (da) 1995-07-03
EP0527887A1 (en) 1993-02-24
IL98033A0 (en) 1992-06-21
PT97562B (pt) 1998-08-31
EP0527887B1 (en) 1995-04-26
ES2071312T3 (es) 1995-06-16
US5698225A (en) 1997-12-16
ATE121625T1 (de) 1995-05-15
CA2082944A1 (en) 1991-11-04
DE69109286T2 (de) 1995-09-28
WO1991016895A1 (en) 1991-11-14
AU7876491A (en) 1991-11-27

Similar Documents

Publication Publication Date Title
PT97562A (pt) Processo para a preparacao de uma composicao farmaceutica contendo um nucleo de diclofenac ou de piroxicamo e um revestimento de cobertura de uma prostaglandina
EA199800477A1 (ru) Производные хинолина
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
MX9302214A (es) Derivados de taxol y proceso para su preparacion
FI904734A0 (fi) Anordning foer maetning av tryckdifferens.
DZ1468A1 (fr) Composés nouveaux.
FI904735A0 (fi) Anordning foer maetning av tryckdifferens.
NO883827L (no) Fremgangsmaate for paafoering av belegg paa flatglass.
BR9914787A (pt) Processo para a preparação de um composto
NO874507L (no) Maskin for trykkstoeping av metalldeler som eventuelt inneholder fibre av keramiske materialer.
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
NO904576L (no) Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter.
FI935676A7 (fi) Entsymaattinen menetelmä heterobisyklisen alkoholienantiomeerin stereoselektiiviseen valmistukseen
YU47973B (sh) S-enantiomerni glutaramidi i postupak za njihovo dobijanje
EP0614853A3 (en) Method of making beta zeolite.
FI892912A0 (fi) Komposition foer framstaellning av artificiella stenmaterialier.
DE69006994D1 (de) Verfahren zur herstellung von antimikrobiellen zubereitungen von 2-(alkylthioäthanamin)hydrohaliden.
PT89029A (pt) Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina
ES513384A0 (es) "metodo para la fabricacion de derivados de la quinolina".
FI906162A0 (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
FI853164A7 (fi) Menetelmä optisesti aktiivisten, substituoitujen 1,4-dihydropyridiinien valmistamiseksi ja niiden käyttö lääkeaineina.
YU47369B (sh) Postupak za optičko razdvajanje 3r-(3-karboksibenzil)-6-(5-fluoro-2-benzotiazolil)m etoksi-4r-hromanola
ES2019857T3 (es) Procedimiento para la fabricacion de aminopropanolderivados de compuestos de 3-(2'-hidroxifenil)-1-propanona.
DE69012034D1 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
ES2008640T3 (es) Derivados de aminopropanol de compuestos de 3-(3-hidroxifenil)-1-propanona, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911104

FG3A Patent granted, date of granting

Effective date: 19980519

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130520